The fund for biotechnology stocks, IBB, has sealed up its price gap beautifully today. This represents an interesting short-sale opportunity with a very good risk/reward ratio.
I decided to instead sell short XBI. It doesn’t have exactly the same setup, but it’s similar, plus it is much more liquid.
